An observational study in Colorectal Cancer, Gastric Cancer and Inflammatory Bowel Diseases, sponsored by Renmin Hospital of Wuhan University. Recruiting at 1 site in China. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2022-04-29.
Sponsored by Renmin Hospital of Wuhan University · Observational
The purposes of this study are to collect and store samples including blood, normal and tumor tissue from patients with colorectal cancer or gastric cancer, to collect and store samples including blood and/or normal gastrointestinal tissue (if available) from patients with non-malignant disease (including, but not limited to, inflammatory bowel disease (IBD), gastric ulcer, hemorrhoids or hernia), and to create a database for the collected samples and allow access to relevant clinical information for current and future protocols.
5,598 studies on the registry are indexed under Colorectal Neoplasms; 1,458 are open to participants now.
This study's planned enrollment of 1,000 is above the median of 250 across 1,226 observational studies indexed under Colorectal Neoplasms.
Browse Colorectal Neoplasms studies →Renmin Hospital of Wuhan University is the lead sponsor of 83 studies on the registry; 27 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Participants who are planning to undergo surgery.
Exclusion Criteria:
Patients suffering from CRC or gastric cancer scheduled to have surgical resection of colon/rectum or stomach.
Other: No intervention will be given to patients.
Patients suffering from non-malignant disease scheduled to have surgery.
Other: No intervention will be given to patients.
Samples are collected at the time of a scheduled surgery that is part of normal treatment. This study will not have any impact on the care or treatment the patient receives.
Confirmation of diagnosis by pathologist
Once tissue is collected, those samples that have a confirmed diagnosis of disease by the pathologist will be used.
Time frame: Up to 3 years
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Renmin Hospital of Wuhan University